Sangamo BioSciences (SGMO) PT Lowered to $6 at RBC Capital
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on Sangamo BioSciences (NASDAQ: SGMO) to $6.00 (from $8.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
- Trex (TREX) PT Raised to $49 at Stifel
- Guidewire (GWRE) PT Raised to $225 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
